Archives
Bsa I (RNase-free): Technical Guide for DNA Cleavage Workflo
2026-06-10
Bsa I (RNase-free) enables precise DNA cleavage for molecular biology research, particularly when RNA integrity must be preserved during gene cloning and DNA manipulation. It is not suitable for diagnostic or clinical use, and should only be used in research workflows requiring RNase-free conditions.
Latrunculin B Inhibitor Workflows: Optimizing Actin Cytoskel
2026-06-09
Latrunculin B stands out for rapid, selective inhibition of actin polymerization—making it indispensable for dissecting cytoskeletal dynamics in cell biology assays. This guide translates reference-backed insights into actionable workflows, troubleshooting tips, and comparative applications for researchers seeking high-confidence actin cytoskeleton disruption.
Calpain Inhibitor I, ALLN: Technical Use in Apoptosis & Isch
2026-06-09
Calpain Inhibitor I, ALLN (SKU A2602) provides targeted inhibition of calpain and cathepsin proteases for researchers studying apoptosis assays and ischemia-reperfusion injury models. This product is not designed for diagnostic or clinical use, and requires strict adherence to solubility and handling protocols to ensure experimental reproducibility.
Mechanistic Insights into Diuron-Induced Acute Renal Injury
2026-06-08
This article analyzes a 2025 study that elucidates the molecular basis of Diuron-induced acute kidney injury using integrated network toxicology and experimental models. The findings reveal a central role for JAK2/STAT1 pathway activation, providing a scientific foundation for future toxicological assessments of this widely used herbicide.
BMS-345541 Hydrochloride: Selective IKK Inhibitor for NF-κB
2026-06-08
BMS-345541 hydrochloride is a highly selective IKK inhibitor that disrupts NF-κB signaling and induces apoptosis in T-ALL models. Its unique binding profile and robust water solubility make it a benchmark tool for inflammation and cancer biology research.
Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto
2026-06-07
This study uncovers a methyltransferase-driven mechanism in Salmonella Typhimurium that enhances bacterial haem biosynthesis, suppresses macrophage phagocytosis, and promotes pathogenesis in mice. The findings advance understanding of how pathogen-derived haem modulates host immune responses and reveal new directions for research into bacterial immune evasion.
Multifunctional Airway Stent Suppresses Tracheal Restenosis
2026-06-06
Zhao et al. (2025) introduce a dual-action airway stent combining anti-inflammatory and anti-angiogenic properties to address tracheal in-stent restenosis (TISR). Preclinical evidence demonstrates the stent’s effectiveness in reducing vascularization, inflammation, and fibroblast activation, offering a promising strategy for improving airway stent outcomes.
GSK2606414 PERK Inhibitor: Optimizing ER Stress and UPR Assa
2026-06-05
GSK2606414 is redefining ER stress research by enabling highly selective and reproducible inhibition of the PERK pathway, powering advanced studies in cancer, neurodegeneration, and protein folding disorders. This article delivers actionable workflow enhancements, troubleshooting strategies, and a practical synthesis of new mechanistic insights from recent literature and reference benchmarks.
Alosetron in Intestinal Stem Cell Polarity: Mechanistic Insi
2026-06-05
Explore how Alosetron, a selective 5-HT3 receptor antagonist, advances intestinal stem cell polarity research. This article uncovers unique mechanistic and assay implications beyond protocol guides, integrating cutting-edge findings with practical applications.
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Advanc
2026-06-04
This article evaluates the development and preclinical validation of intravesical p21 mRNA–loaded lipid nanoparticles (LNPs) as a localized tumor suppressor replacement therapy for bladder cancer. The study demonstrates the efficacy and safety of restoring p21 expression via mRNA-LNPs, providing a promising framework for mRNA-based interventions in non–muscle-invasive bladder tumors.
Alosetron in Intestinal Stem Cell Fate: Beyond 5-HT3 Antagon
2026-06-04
Explore how Alosetron, a selective 5-HT3 receptor antagonist, enables advanced investigation of intestinal stem cell fate and epithelial polarity. This article uniquely integrates mechanistic insights from CDC42-YAP-mTOR research, guiding scientists in GI signaling assays.
Calpain Inhibitor I, ALLN: Technical Guidance for Research U
2026-06-03
Calpain Inhibitor I, ALLN is a potent, selective inhibitor used to modulate calpain and cathepsin activity in apoptosis and ischemia-reperfusion injury research. This compound is unsuitable for diagnostic or clinical applications and should not be integrated into water-based protocols due to its solubility profile.
5-Aminolevulinic acid HCl: Applied Workflows in Heme Biosynt
2026-06-03
5-Aminolevulinic acid HCl empowers researchers to dissect pathogen virulence and immune evasion by enabling precise control of heme biosynthesis pathways. APExBIO’s high-purity formulation streamlines translation from mechanistic discovery to fluorescence-guided resection and advanced infection models.
Dimetridazole Potentiates Cefotaxime Against MDR E. coli
2026-06-02
This study demonstrates that dimetridazole synergistically enhances cefotaxime activity against multidrug-resistant E. coli by disrupting bacterial membranes and modifying fatty acid composition. The findings highlight a promising drug repurposing strategy to combat antimicrobial resistance and revive efficacy of existing antibiotics.
BMS-345541 Hydrochloride: Applied Workflows in Inflammation
2026-06-02
BMS-345541 hydrochloride delivers highly selective IKK inhibition for pinpointing NF-κB-driven inflammation and apoptosis in cancer models. This guide translates bench protocols into actionable, data-backed workflows, with troubleshooting and optimization tips to boost reproducibility in translational research.
699 records 18/47 page Previous Next First page 上5页 1617181920 下5页 Last page